Company: WELNF
Filing Date: 2025-10-31
Form Type: PRE 14A
Source: 0001104659-25-104954
Chunk: 3

Company: Integrated Wellness Acquisition Corp
Filing Date: 2025-10-31
Form: PRE 14A
Chunk 3
---
 public shares (the “Election”)
for a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account (the “Trust Account”)
established in connection with the IPO, including interest not previously released to the Company to pay taxes, divided by the number
of then issued and outstanding Public Shares, regardless of whether or how such public shareholders vote on the proposals at the Meeting;
however, redemption payments for Elections in connection with this Meeting will only be made if the M&A Amendment Proposals receive the requisite shareholder approvals. Further, the Company shall not redeem any Class A Ordinary Shares held by the Sponsor (defined below) or its affiliates or the directors or officers of the Company.

The purpose of the M&A
Amendment Proposals and, if necessary, the Adjournment Proposal, is to allow the Company additional time to complete its initial business
combination (the “Business Combination”). We originally had 15 months from the consummation of our initial public offering,
or until March 13, 2023, to consummate our initial business combination. However, as requested by its prior sponsor and as permitted
under its M&A, we extended the date by which we must consummate an initial business combination by an additional three months until
June 13, 2023.

On June 2, 2023, the
Company held an extraordinary general meeting, at which its shareholders approved, among others, a proposal to extend the date by which
it would be required to consummate a business combination from June 13, 2023 to December 13, 2023 (or such earlier date as determined
by the Board) (the “June 2023 Extension”). On December 11, 2023, the Company held an extraordinary general
meeting, at which its shareholders approved, among others, a proposal to extend the date by which it would be required to consummate a
business combination from December 13, 2023 to December 13, 2024 (or such earlier date as determined by the Board) (the “December 2023 Extension”).

On December 11, 2024, the Company held an
extraordinary general meeting, at which its shareholders approved, among others, a proposal to extend the date by which it would be required
to consummate a business combination from December 13, 2024 to December 15, 2025 (or such earlier date as determined by the
Board) (